Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE) will participate in Chardan’s 6th Annual Genetic Medicines & Cell Therapy Manufacturing Summit on April 26, 2022, at 2:30 p.m. ET. CEO Paul Bolno and SVP Sri Vaddeboina will join an analyst-led fireside chat, which will be streamed live on their Investor Relations page. Wave Life Sciences focuses on delivering innovative genetic medicines for devastating diseases using its PRISM platform for the precise design and production of stereopure oligonucleotides. A replay will be available shortly after the event on their website.

CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, and Sri Vaddeboina, PhD, Senior Vice President, Chemistry, Manufacturing and Controls, are scheduled to participate virtually in an analyst-led fireside chat at Chardan’s 6th Annual Genetic Medicines & Cell Therapy Manufacturing Summit on Tuesday, April 26, 2022, at 2:30 p.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com 

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

What event is Wave Life Sciences participating in on April 26, 2022?

Wave Life Sciences will participate in Chardan’s 6th Annual Genetic Medicines & Cell Therapy Manufacturing Summit.

Who will represent Wave Life Sciences at the summit on April 26, 2022?

CEO Paul Bolno and SVP Sri Vaddeboina will represent Wave Life Sciences at the summit.

What time does the Wave Life Sciences chat start on April 26, 2022?

The chat is scheduled to begin at 2:30 p.m. ET.

Where can I watch the Wave Life Sciences presentation?

The presentation can be viewed live on the Investor Relations page of Wave Life Sciences' corporate website.

Will there be a replay available after the event on April 26, 2022?

Yes, a replay of the presentation will be archived on their website for a limited time.